GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?

Neurogastroenterol Motil. 2019 Oct;31(10):e13684. doi: 10.1111/nmo.13684. Epub 2019 Jul 16.

Abstract

Background: Patients with irritable bowel syndrome (IBS) may experience postprandial symptom exacerbation. Nutrients stimulate intestinal release of glucagon-like peptide 1 (GLP-1), an incretin hormone with known gastrointestinal effects. However, prior to the postprandial rise in GLP-1, levels of the hunger hormone, ghrelin, peak. The aims of this study were to determine if ghrelin sensitizes colonic intrinsic and extrinsic neurons to the stimulatory actions of a GLP-1 receptor agonist, and if this differs in a rat model of IBS.

Methods: Calcium imaging of enteric neurons was compared between Sprague Dawley and Wistar Kyoto rats. Colonic contractile activity and vagal nerve recordings were also compared between strains.

Key results: Circulating GLP-1 concentrations differ between IBS subtypes. Mechanistically, we have provided evidence that calcium responses evoked by exendin-4, a GLP-1 receptor agonist, are potentiated by a ghrelin receptor (GHSR-1) agonist, in both submucosal and myenteric neurons. Although basal patterns of colonic contractility varied between Sprague Dawley and Wister Kyoto rats, the capacity of exendin-4 to alter smooth muscle function was modified by a GHSR-1 agonist in both strains. Gut-brain signaling via GLP-1-mediated activation of vagal afferents was also potentiated by the GHSR-1 agonist.

Conclusions & inferences: These findings support a temporal interaction between ghrelin and GLP-1, where the preprandial peak in ghrelin may temporarily sensitize colonic intrinsic and extrinsic neurons to the neurostimulatory actions of GLP-1. While the sensitizing effects of the GHSR-1 agonist were identified in both rat strains, in the rat model of IBS, underlying contractile activity was aberrant.

Keywords: colonic contractility; ghrelin; glucagon-like peptide 1; myenteric; vagal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colon / drug effects*
  • Colon / innervation
  • Colon / metabolism
  • Constipation / metabolism
  • Constipation / physiopathology
  • Diarrhea / metabolism
  • Diarrhea / physiopathology
  • Electrophysiological Phenomena
  • Enteric Nervous System / cytology
  • Enteric Nervous System / drug effects
  • Exenatide / pharmacology*
  • Ghrelin / metabolism
  • Glucagon-Like Peptide 1 / metabolism
  • Glucagon-Like Peptide-1 Receptor / agonists
  • Humans
  • Incretins / pharmacology*
  • Irritable Bowel Syndrome / metabolism*
  • Irritable Bowel Syndrome / physiopathology
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects
  • Neurons / drug effects*
  • Neurons / metabolism
  • Rats
  • Rats, Inbred WKY
  • Rats, Sprague-Dawley
  • Receptors, Ghrelin / agonists
  • Vagus Nerve / drug effects
  • Vagus Nerve / metabolism

Substances

  • Ghrelin
  • Glucagon-Like Peptide-1 Receptor
  • Incretins
  • Receptors, Ghrelin
  • Glucagon-Like Peptide 1
  • Exenatide